Pharmnovo Wraps Drug Manufacturing For PN6047 Phase Iia Study
09 Apr 2026 //
PHARMIWEB
Pharmnovo Initiates Ph 2a Trial Of PN6047 For Neuropathic Pain
09 Oct 2025 //
PHARMIWEB
PharmNovo appoints CFO and Clinical Lead to strengthen the organisation
05 Sep 2022 //
CISION

Market Place
Sourcing Support